Hasbani Issued A Decision On The Regulation Of Surgical Operations In Specialized Hospitals And Remi

Hasbani Issued a Decision on the Regulation of Surgical Operations in Specialized Hospitals and Reminded Beauty Centers of the Legal Deadline Given until August to Settle their Situation

Deputy Prime Minister Health Minister Ghassan Hasbani held a press conference in his office at the Ministry of Public Health, Bir Hassan during which he tackled the organizational frames of beauty Centers and specialized hospitals.
He started by saying: “After the repetitive complaints received by the Ministry of Public Health on accidents and infringements occurring in the sector of Aesthetic Medicine, and as a result of what happened yesterday after the liposuction operation in a specialized hospital, we realized that it is our duty to inform you about the approach of the Ministry to the regulation of aesthetic sector and the actions taken and that being completed through regulatory actions."

Beauty Centers

He added: "The Ministry of Public Health followed up the work of the Parliamentary Health Commission for the regulation of Medical Beauty Centers licenses that resulted in the issuance of decision No. 30 of 10 February 2017, which was published in The Official gazette on February 16, 2017. The Definition of Aesthetic Medicine, its centers and the medical work they are authorized to carry out are regulated by Law which has determined the medical specializations that have the right to hold a permission to practice the profession of Aesthetic medicine. According to the law, the existing Beauty Centers are given a 6 month period to regularize their legal situation as of the date of the publication of this law, i.e. 16 August 2017, under penalty of closing these centers by a decision of Health Minister.

Specialized Hospitals

Health Minister added that he has issued a regulatory decision for specialized hospitals related to the regulation of surgeries which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not be carried out in places other than specialized hospitals which include an intensive care division which holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

Hasbani stressed that this decision will be immediately communicated to all concerned parties.

Death Case

Hasbani talked also about the recent tragic death of the woman who underwent a liposuction opertaion in a specialized hospital and said: “the Public Prosecution and the Syndicate of Physicians have launched investigations and the Ministry of Public Health has started to investigate and complete the files. The Committee of investigations will meet in the Ministry in order to consider the details of this case and provide consultancies to the Syndicate and Justice where needed.

...

194

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06DA02	ALZEPIL	G	Donepezil HCl - 10mg	10mg	Tablet	1,908,256 L.L
J01DH51	AMANAM 500	G	Imipenem - 500mg, Cilastatin - 500mg	500mg	Injectable powder for solution	997,131 L.L
A10BB12	AMARYL	B	Glimepiride - 1mg	1mg	Tablet	231,141 L.L
A10BB12	AMARYL	B	Glimepiride - 2mg	2mg	Tablet	233,829 L.L
A10BB12	AMARYL	B	Glimepiride - 3mg	3mg	Tablet	392,402 L.L
A10BB12	AMARYL	B	Glimepiride - 4mg	4mg	Tablet	392,402 L.L
J02AA01	AMBISOME	B	Liposomal Amphotericin B - 50mg	50mg	Injectable powder for liposomal dispersion	13,126,040 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 1mg	1mg	Tablet	137,072 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 2mg	2mg	Tablet	139,760 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 3mg	3mg	Tablet	215,015 L.L
A10BB12	AMEPRIDE	G	Glimepiride - 4mg	4mg	Tablet	215,015 L.L
J01GB06	AMICINE	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	1,749,683 L.L
J01GB06	AMIKACIN SULPHATE	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	372,244 L.L
J01GB06	AMIKACIN-ORBUCELL	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	3,711,565 L.L
R03DA05	AMINOPHYLLINE	G	Aminophylline - 100mg	100mg	Tablet, scored	445,388 L.L
R03DA05	AMINOPHYLLINE ADULTS	G	Aminophylline - 350mg	350mg	Suppository	244,451 L.L
R03DA05	AMINOPHYLLINE CHILDREN	G	Aminophylline - 100mg	100mg	Suppository	203,496 L.L
R03DA05	AMINOPHYLLINE RENAUDIN	G	Aminophylline - 250mg/10ml	2.5%	Injectable solution	739,113 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
C01BD01	AMIODARONE BIOGARAN	G	Amiodarone (HCl) - 200mg	200mg	Tablet	345,368 L.L
C08CA01	AMLINE	G	Amlodipine - 5mg	5mg	Tablet, scored	358,358 L.L
C08CA01	AMLINE	G	Amlodipine - 10mg	10mg	Tablet	662,962 L.L
C08CA01	AMLO TAD	G	Amlodipine besylate - 5mg	5mg	Tablet	744,489 L.L
C08CA01	AMLOCARD	G	Amlodipine (besylate) - 5mg	5mg	Tablet	473,545 L.L
C08CA01	AMLOCARD 10	G	Amlodipine (besylate) - 10mg	10mg	Tablet	870,298 L.L
C08CA01	AMLOCOEUR	G	Amlodipine - 5mg	5mg	Tablet	362,198 L.L
C08CA01	AMLODAR 10	G	Amlodipine (besylate) - 10mg	10mg	Capsule	671,921 L.L
C08CA01	AMLODAR 5	G	Amlodipine (besylate) - 5mg	5mg	Capsule	362,837 L.L

...

194